Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Camporesi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biomarker Insights|September 11, 2020
Fluid Biomarkers for Synaptic Dysfunction and LossElena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Acta Neuropathologica Communications|February 1, 2021
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkersElena Camporesi, Tammaryn Lashley, Johan Gobom, et al.
Behavioural Brain Research|December 3, 2014
27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in miceMaura Heverin, Silvia Maioli, Therese Pham, et al.
Journal of Neurochemistry|November 29, 2020
Molecular forms of neurogranin in cerebrospinal fluidFaisal Hayat Nazir, Elena Camporesi, Gunnar Brinkmalm, et al.
Ebiomedicine|January 6, 2022
Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometryElena Camporesi, Johanna Nilsson, Agathe Vrillon, et al.
Acta Neuropathologica Communications|April 24, 2023
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillationsJessica Brown, Elena Camporesi, Juan Lantero-Rodriguez, et al.
Molecular Neurodegeneration|August 31, 2018
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidaseBruno Becker, Faisal Hayat Nazir, Gunnar Brinkmalm, et al.
Alzheimer'S Research & Therapy|November 3, 2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patientsMatthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, et al.
Molecular Neurobiology|September 8, 2022
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ PeptidesLinda Hanbouch, Béatrice Schaack, Amal Kasri, et al.
Journal of Neurochemistry|August 18, 2025
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological DisordersSergio Escamilla, Rocío Pérez-González, Carmen Márquez-Marco, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biomarker Insights|September 11, 2020
Fluid Biomarkers for Synaptic Dysfunction and LossElena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Acta Neuropathologica Communications|February 1, 2021
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkersElena Camporesi, Tammaryn Lashley, Johan Gobom, et al.
Behavioural Brain Research|December 3, 2014
27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in miceMaura Heverin, Silvia Maioli, Therese Pham, et al.
Journal of Neurochemistry|November 29, 2020
Molecular forms of neurogranin in cerebrospinal fluidFaisal Hayat Nazir, Elena Camporesi, Gunnar Brinkmalm, et al.
Ebiomedicine|January 6, 2022
Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometryElena Camporesi, Johanna Nilsson, Agathe Vrillon, et al.
Acta Neuropathologica Communications|April 24, 2023
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillationsJessica Brown, Elena Camporesi, Juan Lantero-Rodriguez, et al.
Molecular Neurodegeneration|August 31, 2018
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidaseBruno Becker, Faisal Hayat Nazir, Gunnar Brinkmalm, et al.
Alzheimer'S Research & Therapy|November 3, 2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patientsMatthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, et al.
Molecular Neurobiology|September 8, 2022
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ PeptidesLinda Hanbouch, Béatrice Schaack, Amal Kasri, et al.
Journal of Neurochemistry|August 18, 2025
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological DisordersSergio Escamilla, Rocío Pérez-González, Carmen Márquez-Marco, et al.
Pageof 2